Learn more about a care delivery model which can identify, implement, and expedite patient lung nodule care in real time and provide consistent follow-up along the continuum of care.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Recognizing the need for better care coordination and prompted by the experience of a patient partner, WellSpan Health embarked on a multispecialty effort to reimagine how incidental nodules are managed through the lens of the Quadruple Aim: improving the patient and provider experience, lowering per capita cost of care, and optimizing the health of populations. The new care delivery model identifies, implements, and expedites patient lung nodule care in real time and provides consistent follow-up along the continuum of care. The result: patient outcomes are optimized by early intervention of undiagnosed lung cancer. This care delivery model for incidental lung nodule findings can serve as a springboard for other incidental findings and help detect other early carcinomas.
Guest:
Nikhilesh Korgaonkar, MD, MBA, FACS
Thoracic Surgeon
Chief Medical Officer
Wellspan Health Cancer Institute
“One thing I will say is that I cannot understate the importance of marking sure all the stakeholders are on board with a program like this. We have stakeholders in radiology, in primary care, in pulmonology, and, or course, in administration. And this program is the result of making sure everyone was on the same page with the goals and the desired outcomes of this program. And that really set this program for success.”
Read more in “Reimagining Healthcare for Incidental Lung Nodules” in Volume 38, Number 2, Oncology Issues.
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
